OSE Pharma SA - Asset Resilience Ratio

Latest as of June 2025: 29.41%

OSE Pharma SA (OSE) has an Asset Resilience Ratio of 29.41% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read OSE total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€30.64 Million

≈ $35.82 Million USD Cash + Short-term Investments

Total Assets

€104.18 Million

≈ $121.80 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how OSE Pharma SA's Asset Resilience Ratio has changed over time. See what is OSE Pharma SA's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down OSE Pharma SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see OSE Pharma SA market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€14.44 Million	13.86%
Short-term Investments	€16.20 Million	15.55%
Total Liquid Assets	€30.64 Million	29.41%

Asset Resilience Insights

Very High Liquidity: OSE Pharma SA maintains exceptional liquid asset reserves at 29.41% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

OSE Pharma SA Industry Peers by Asset Resilience Ratio

Compare OSE Pharma SA's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
Tubize-Fin BR:TUB	Biotechnology	0.05%
BrightGene Bio Medical Technology C SHG:688166	Biotechnology	1.00%
Dashenlin Pharm Grp Co Ltd SHG:603233	Biotechnology	0.02%
Staidson Beijing Biopharma SHE:300204	Biotechnology	7.93%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	41.25%
Ardelyx Inc NASDAQ:ARDX	Biotechnology	41.14%
Xiangxue Pharmaceutical SHE:300147	Biotechnology	0.05%

Annual Asset Resilience Ratio for OSE Pharma SA (2015–2024)

The table below shows the annual Asset Resilience Ratio data for OSE Pharma SA.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	41.70%	€51.69 Million ≈ $60.43 Million	€123.96 Million ≈ $144.92 Million	+26.38pp
2023-12-31	15.32%	€12.57 Million ≈ $14.69 Million	€82.05 Million ≈ $95.93 Million	+7.56pp
2022-12-31	7.75%	€7.11 Million ≈ $8.31 Million	€91.67 Million ≈ $107.17 Million	-25.10pp
2021-12-31	32.85%	€33.35 Million ≈ $38.99 Million	€101.52 Million ≈ $118.69 Million	+3.00pp
2020-12-31	29.86%	€28.91 Million ≈ $33.80 Million	€96.85 Million ≈ $113.22 Million	+1.01pp
2019-12-31	28.85%	€25.64 Million ≈ $29.98 Million	€88.89 Million ≈ $103.92 Million	+18.50pp
2018-12-31	10.35%	€7.96 Million ≈ $9.30 Million	€76.90 Million ≈ $89.91 Million	-2.96pp
2017-12-31	13.31%	€10.29 Million ≈ $12.03 Million	€77.35 Million ≈ $90.43 Million	-6.53pp
2016-12-31	19.84%	€17.77 Million ≈ $20.77 Million	€89.55 Million ≈ $104.69 Million	-14.29pp
2015-12-31	34.13%	€5.80 Million ≈ $6.78 Million	€17.00 Million ≈ $19.87 Million	--

pp = percentage points

About OSE Pharma SA

PA:OSE France Biotechnology

Market Cap

$100.23 Million

€85.73 Million EUR

Market Cap Rank

#19647 Global

#299 in France

Share Price

€3.82

Change (1 day)

-3.29%

52-Week Range

€3.02 - €7.20

All Time High

€15.00